Similar Items: Maintenance Metronomic Chemotherapy in Treatment of Metastatic Colorectal Cancer
- Characteristics of Patients With Advanced or Metastatic Urothelial Cancer Unable to Complete Six Cycles Chemotherapy
- Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer
- Optimizing Outcomes in Elderly HNSCC: Efficacy of UFT Metronomic Therapy
- Revised tumor burden score for prognostic stratification in metastatic colorectal cancer patients receiving immunotherapy: a retrospective study
- First-Line Tislelizumab Plus Chemotherapy for Advanced or Metastatic Squamous Non-Small Cell Lung Cancer: 4-Year Long-Term Follow-Up from RATIONALE-307
- Survival Outcomes and Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated First-Line mFOLFOXIRI Plus Bevacizumab: A Real-World Study in Vietnam